Cardiology Perspective
- Therapies 'Not Used Enough' in Patients With T2D and CVD Risk
- ACC 2022: Unmet Needs and Emerging Therapies in Lipid Management
- Aspirin in Primary Prevention of CVD: Rational Use
- Key Points From the New Heart Failure Guidelines
- Paxlovid Is Here: A Pharmacist's Prescribing Pearls
- Is the AMA Irrelevant or the Main Player?
- Apr 29 2022 This Week in Cardiology
- Cure, Prevent, or Manage All Disease: The Chan Zuckerberg Initiative's Bold Plan Is Already Working
- American College of Cardiology 2022: Reflections on Lipid Management
- LIVE-Yoga: Benefit of Yoga as Adjunctive Therapy to Reduce Recurrent Vasovagal Syncope
- New Revascularization Guidelines: Key Points and Controversies
- Diabetes and Heart Disease Highlights From ACC 2022
- Top Abstracts in Atherosclerosis and Lipid Management From ACC 2022
- Apr 22 2022 This Week in Cardiology
- Infographic: Physician Incomes Gain, Pay Gaps Remain
- Trans Women in Female Sports: A Sports Scientist's Take
- Animal Reservoirs, Immunocompromised Hosts: COVID Dangers Ahead
- Type 2 Diabetes With ASCVD
- Battling Obesity by Breaking Down Barriers
- Episode 6: Emerging and Novel Therapeutics in the Management of PsA